Clinical tools and nomograms
Calculators validated by leading institutions (MSKCC, UCSF, Cleveland Clinic, EAU) that we use during consultations to estimate risk, prognosis, continence and erectile function — gathered in one place.
Clínica Uro Onco calculators
Overall survival at 3 and 5 years based on PET-PSMA parameters (Karpinski MJ et al., Eur Urol 2025).
Open tool →Bladder cancerRecurrence risk — bladder cancer (EAU)Risk stratification of non-muscle-invasive bladder tumors according to the EAU.
Open tool →ProstateI-PSS — urinary symptom scoreInternational Prostate Symptom Score questionnaire, with immediate results.
Open tool →Sexual functionIIEF-5 — erectile functionInternational Index of Erectile Function (5 questions), useful before and after treatment.
Open tool →Prostate cancerBiochemical recurrence (BCR) calculatorRisk after prostatectomy or radiotherapy — EAU BCR risk groups.
Open calculator ↗Pre-biopsy assessment and screening
For men without a diagnosis who have an abnormal PSA or a suspicious MRI.
Prostate cancer risk in men aged 55 or older: PSA, digital rectal exam and family history.
Open ↗MSKCCRisk of high-grade cancer on biopsyLikelihood of finding aggressive cancer on the initial biopsy.
Open ↗NorthwesternMy nMRIskProbability of significant cancer using MRI data (PI-RADS) and PSA density.
Open ↗cancernomograms.comRisk on fusion biopsy (ID 472)Benign or malignant findings on image-fusion-guided biopsies.
Open ↗Pre-treatment assessment
For diagnosed patients, before deciding between surgery, radiotherapy or surveillance.
Extent of disease and expected outcomes after prostatectomy.
Open ↗UCSFCAPRA Score (ID 23)Probability of recurrence at 5, 10 or 15 years after treatment.
Open ↗cancernomograms.comLymph node invasion (ID 292)Helps decide on pelvic lymph node dissection during surgery.
Open ↗MSKCCMale life expectancyCancer risk versus other causes of death over 15 years.
Open ↗cancernomograms.com10-year recurrence (ID 64)Likelihood of cure or disease recurrence a decade after radical surgery.
Open ↗cancernomograms.com10-year life expectancy (ID 18)Life expectancy based on comorbidities.
Open ↗Post-treatment assessment
For those already treated: recurrence, salvage treatment and quality of life.
For undetectable PSA: likelihood of cure at up to 10 years.
Open ↗cancernomograms.comSalvage radiotherapy (ID 29)Success of salvage radiotherapy if PSA starts rising again.
Open ↗MSKCCBiochemical recurrenceLong-term risk when PSA rises after treatment.
Open ↗cancernomograms.comMortality after recurrence (ID 352)Cancer-specific mortality in men with biochemical recurrence.
Open ↗cancernomograms.comErectile function — preoperative (ID 3052)Estimated recovery of erections after robotic surgery.
Open ↗cancernomograms.comErectile function — postoperative (ID 3032)Recovery of erections based on surgical data.
Open ↗cancernomograms.comUrinary continence (ID 2754)Probability of regaining urinary control (anatomy and age).
Open ↗Active surveillance
For low-risk cancer under monitoring.
Biopsy frequency and risk of progression over the years.
Open ↗cancernomograms.comRisk of reclassification (ID 372)Likelihood of reclassification to more aggressive disease at the next biopsy.
Open ↗cancernomograms.comAdverse pathology (ID 3872)Probability of hidden, more serious disease in low-risk patients.
Open ↗Overall and geriatric health
To assess tolerance to treatment in older patients.
Specialized uro-oncology evaluation
Accurate diagnosis, an individualized plan and an integrated team — robotic surgery, medical oncology and rehabilitation in one place. In person in São Paulo or via telemedicine.
Book a consultation Second opinion